Trade Summary

2 days ago, Jones Christy, serving as Dir at Beta Bionics, Inc. (BBNX), sold 2,811 shares at $14.00 per share, for a total transaction value of $39,354.00. Following this transaction, Jones Christy now holds 27,400 shares of BBNX.

This sale represents a 9.30% decrease in Jones Christy's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 6:05 PM ET, 1 day after the trade was made.

Beta Bionics, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.